Autolus Therapeutics (AUTL) Operating Margin (2018 - 2025)
Historic Operating Margin for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to 337.93%.
- Autolus Therapeutics' Operating Margin changed N/A to 337.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 535.8%, marking a year-over-year increase of 16308700.0%. This contributed to the annual value of 2385.63% for FY2024, which is 81974700.0% up from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' Operating Margin is 337.93%.
- In the past 5 years, Autolus Therapeutics' Operating Margin ranged from a high of 292.58% in Q2 2025 and a low of 261600.0% during Q4 2024
- Its 5-year average for Operating Margin is 27712.83%, with a median of 2303.26% in 2023.
- The largest annual percentage gain for Autolus Therapeutics' Operating Margin in the last 5 years was 187687600bps (2023), contrasted with its biggest fall of -89912500bps (2023).
- Quarter analysis of 5 years shows Autolus Therapeutics' Operating Margin stood at 17099.58% in 2021, then skyrocketed by 98bps to 318.39% in 2022, then plummeted by -3219bps to 10567.73% in 2023, then crashed by -2375bps to 261600.0% in 2024, then skyrocketed by 100bps to 337.93% in 2025.
- Its Operating Margin was 337.93% in Q3 2025, compared to 292.58% in Q2 2025 and 726.34% in Q1 2025.